中文 | English
Return
Total: 27 , 1/3
Show Home Prev Next End page: GO
Author:(Jincheng HE)

1.Predicting the surgical difficulty,complications and prognosis of kidney tumors based on anatomical features:advances in renal tumor scoring systems

Gen LI ; Yuhao YU ; Xuexing FAN ; Jincheng LI ; Jiasong LI ; Pugui LI ; Xiaopen CHEN ; He WANG ; Geng ZHANG ; Yong WANG

Journal of Modern Urology 2025;30(4):355-363

2.Correlation of MET Status with Clinicopathological Features and Prognosis of Advanced Prostatic Acinar Adenocarcinoma

Weiying HE ; Wenjia SUN ; Huiyu LI ; Yanggeling ZHANG ; De WU ; Chunxia AO ; Jincheng WANG ; Yanan YANG ; Xuexue XIAO ; Luyao ZHANG ; Xiyuan WANG ; Junqiu YUE

Cancer Research on Prevention and Treatment 2025;52(8):698-704

3.Natural products for the treatment of age-related macular degeneration: New insights focusing on mitochondrial quality control and cGAS/STING pathway.

Xuelu XIE ; Shan LIAN ; Wenyong YANG ; Sheng HE ; Jingqiu HE ; Yuke WANG ; Yan ZENG ; Fang LU ; Jingwen JIANG

Journal of Pharmaceutical Analysis 2025;15(5):101145-101145

4.Causal Associations between Particulate Matter 2.5 (PM 2.5), PM 2.5 Absorbance, and Inflammatory Bowel Disease Risk: Evidence from a Two-Sample Mendelian Randomization Study.

Xu ZHANG ; Zhi Meng WU ; Lu ZHANG ; Bing Long XIN ; Xiang Rui WANG ; Xin Lan LU ; Gui Fang LU ; Mu Dan REN ; Shui Xiang HE ; Ya Rui LI

Biomedical and Environmental Sciences 2025;38(2):167-177

5.Daily maintenance management and repair case analysis of cooling system of superconducting magnetic resonance

Lixia CHEN ; Yali WU ; Jincheng ZHANG ; Dawei HE

China Medical Equipment 2024;21(10):202-205

6.Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma.

Yubing ZHOU ; Xinyu HE ; Yanan JIANG ; Zitong WANG ; Yin YU ; Wenjie WU ; Chenyang ZHANG ; Jincheng LI ; Yaping GUO ; Xinhuan CHEN ; Zhicai LIU ; Jimin ZHAO ; Kangdong LIU ; Zigang DONG

Frontiers of Medicine 2023;17(2):290-303

7.Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial.

Chengyuan GU ; Zengjun WANG ; Tianxin LIN ; Zhiyu LIU ; Weiqing HAN ; Xuhui ZHANG ; Chao LIANG ; Hao LIU ; Yang YU ; Zhenzhou XU ; Shuang LIU ; Jingen WANG ; Linghua JIA ; Xin YAO ; Wenfeng LIAO ; Cheng FU ; Zhaohui TAN ; Guohua HE ; Guoxi ZHU ; Rui FAN ; Wenzeng YANG ; Xin CHEN ; Zhizhong LIU ; Liqiang ZHONG ; Benkang SHI ; Degang DING ; Shubo CHEN ; Junli WEI ; Xudong YAO ; Ming CHEN ; Zhanpeng LU ; Qun XIE ; Zhiquan HU ; Yinhuai WANG ; Hongqian GUO ; Tiwu FAN ; Zhaozhao LIANG ; Peng CHEN ; Wei WANG ; Tao XU ; Chunsheng LI ; Jinchun XING ; Hong LIAO ; Dalin HE ; Zhibin WU ; Jiandi YU ; Zhongwen FENG ; Mengxiang YANG ; Qifeng DOU ; Quan ZENG ; Yuanwei LI ; Xin GOU ; Guangchen ZHOU ; Xiaofeng WANG ; Rujian ZHU ; Zhonghua ZHANG ; Bo ZHANG ; Wanlong TAN ; Xueling QU ; Hongliang SUN ; Tianyi GAN ; Dingwei YE

Chinese Medical Journal 2023;136(10):1207-1215

8.Comparison of clinical efficacy between laparoscopic and open radical resection of hilar cholangiocarcinoma

Cheng ZHANG ; Dongjun AN ; Yang WANG ; Lin YANG ; Jintao WANG ; Li HAN ; Baoguo ZHAO ; Boqiang HAN ; Yao XU ; Jincheng HE

Chinese Journal of General Surgery 2023;38(1):17-22

9.Research progress of microglia regulating phagocytosis of apoptotic neurons after intracerebral hemorrhage

Jincheng MENG ; Chong ZHANG ; Sinan JIN ; Wei HUA ; He WU

Chinese Journal of Neurology 2023;56(2):198-203

10.Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition.

Yaochen XIE ; Qian ZHOU ; Qiaojun HE ; Xiaoyi WANG ; Jincheng WANG

Acta Pharmaceutica Sinica B 2023;13(6):2383-2402

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 27 , 1/3 Show Home Prev Next End page: GO